Atherosclerosis: Open Access
Open Access

Atherosclerosis, often referred to as "the silent killer," is a progressive condition in which fatty deposits, cholesterol, and other substances build up within the walls of arteries. This plaque buildup narrows and hardens the arteries, reducing blood flow and significantly increasing the risk of heart attack, stroke, and other cardiovascular events. Despite its widespread impact, the early stages of atherosclerosis often go unnoticed, which makes early diagnosis and effective treatment essential for managing the condition. Recent advancements in medical research and technology have led to ground breaking progress in both the diagnosis and treatment of atherosclerosis. In this article, we will explore some of the latest breakthroughs in understanding, diagnosing, and treating this potentially life-threatening condition [1].

Description

Breakthroughs in diagnosis

Accurate and early diagnosis of atherosclerosis is essential for preventing its progression and reducing the risk of severe cardiovascular events. In recent years, new diagnostic tools and imaging techniques have emerged, offering more precise ways to detect and evaluate atherosclerosis.

Advanced imaging techniques: Traditional methods of diagnosing atherosclerosis, such as physical exams and blood tests, often fail to detect the condition until it reaches a more advanced stage. However, modern imaging technologies have significantly improved early detection [2].

Computed tomography angiography (CTA): CTA is a non-invasive imaging technique that uses advanced CT scans to create detailed images of blood vessels, allowing physicians to detect plaque buildup and assess the degree of arterial narrowing. CTA has become a valuable tool in identifying atherosclerosis in its early stages, particularly in high-risk individuals.

Magnetic resonance angiography (MRA): MRA uses magnetic fields and radio waves to create images of blood vessels and can detect even subtle changes in the arteries that may indicate the early stages of atherosclerosis. This technique helps doctors evaluate blood flow and artery health without the need for invasive procedures [3].

Ultrasound imaging: High-resolution ultrasound imaging has also made significant strides in detecting plaque buildup and monitoring the progression of atherosclerosis. By using sound waves to create real-time images of the arteries, doctors can evaluate blood flow and identify problem areas before they cause serious complications.

Biomarkers and blood tests: In addition to imaging techniques, researchers are exploring specific biomarkers in the blood that can help identify early signs of atherosclerosis. These biomarkers, such as inflammatory proteins and lipid levels, provide insight into the underlying causes of plaque buildup and the overall health of the arteries [4].

C-reactive protein (CRP): Elevated levels of CRP, an inflammatory marker, have been associated with a higher risk of atherosclerosis and cardiovascular disease. New tests are being developed to measure CRP more accurately, allowing for better risk assessment [5].

Lipoprotein(a) : High levels of Lp(a) have been linked to an increased risk of atherosclerosis, and testing for this marker has become more widespread. Genetic factors influence Lp(a) levels, making it a key target for early detection, especially in individuals with a family history of cardiovascular disease [6].

Genetic testing and personalized risk assessment: Advances in genomics have paved the way for personalized medicine in cardiovascular care. Genetic tests can now help identify individuals with an increased genetic predisposition to atherosclerosis, allowing for earlier intervention. Researchers have identified several genes that influence cholesterol metabolism, inflammation, and arterial function, providing valuable insights into an individual’s risk level [7]. By combining genetic testing with lifestyle assessments and family medical history, doctors can offer personalized recommendations for managing risk factors.

Breakthroughs in treatment

As diagnostic tools have advanced, so too have treatment options for atherosclerosis. Treatment now focuses not only on managing risk factors but also on actively reversing plaque buildup and improving vascular health. Here are some of the latest breakthroughs in atherosclerosis treatment:

Gene therapy: Although still in the experimental stage, gene therapy has shown great promise in treating atherosclerosis by targeting the root causes of plaque buildup. Researchers are investigating ways to deliver therapeutic genes directly to the bloodstream to improve cholesterol metabolism, reduce inflammation, and enhance endothelial function (the health of the blood vessel lining).

One area of focus is the use of gene therapy to increase the production of apolipoprotein A-I (apoA-I), a key protein involved in removing excess cholesterol from the bloodstream. Early studies have shown that gene therapy can help reverse plaque buildup, particularly in animal models, and researchers are hopeful that these techniques will be successful in humans in the near future [8].

Endovascular procedures and stenting: For individuals with advanced atherosclerosis, minimally invasive endovascular procedures have revolutionized treatment. These procedures can be used to open up blocked arteries, restore blood flow, and prevent heart attacks or strokes.

Angioplasty and stenting: In this procedure, a balloon is used to widen narrowed arteries, and a stent (a small mesh tube) is inserted to keep the artery open. Newer, more advanced stents are designed to be more effective and less prone to complications like restenosis (re-narrowing of the artery). Drug-eluting stents, which release medication to prevent blood clots, have become increasingly popular.

Atherectomy: This procedure involves the removal of plaque from the arteries using a catheter with a rotating blade. It is typically used when plaque is too hard to be treated with angioplasty or stenting alone.

Lifestyle modifications: A key to long-term management While medical treatments are essential, lifestyle modifications remain a cornerstone of atherosclerosis management. Diet, exercise, and stress management can significantly impact the progression of the disease.

Dietary changes: A heart-healthy diet that is low in saturated fats, trans fats, and cholesterol, and high in fruits, vegetables, whole grains, and healthy fats, is key to preventing and managing atherosclerosis.

Regular physical activity: Exercise helps lower blood pressure, improve cholesterol levels, and reduce inflammation, all of which contribute to better arterial health.

Stress reduction: Chronic stress has been shown to contribute to inflammation and poor cardiovascular health. Techniques such as meditation, yoga, and mindfulness can help manage stress levels.

Conclusion

Atherosclerosis continues to be one of the leading causes of cardiovascular disease, but thanks to recent breakthroughs in diagnosis and treatment, there is renewed hope for patients and healthcare providers alike. Advanced imaging techniques, genetic testing, and blood biomarkers now allow for earlier detection and more personalized care, while innovative treatments like PCSK9 inhibitors and gene therapy offer new ways to manage the condition. In addition, minimally invasive procedures like angioplasty and atherectomy provide effective solutions for patients with advanced disease. With these developments, healthcare professionals are better equipped to manage and even reverse atherosclerosis, providing individuals with a better chance at a long, healthy life. However, lifestyle changes remain critical in the long-term prevention and management of this condition, making heart-healthy habits essential for maintaining cardiovascular health.

Acknowledgement

None

Conflict of Interest

None

References

1. Becker LM, Chen SH, Rodor J, de Rooij LP, Baker AH, et al. (2022) Deciphering endothelial heterogeneity in health and disease at single cell resolution: progress and perspectives. Cardiovasc Res 119: 6-27.

Indexed at, Google Scholar, Crossref

2. Grootaert MO, Bennett MR (2021) Vascular smooth muscle cells in atherosclerosis: time for a re-assessment. Cardiovasc Res 117: 2326-2339.

Indexed at, Google Scholar, Crossref

3. Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir EAD, et al. (2019) Single-cell immune landscape of human atherosclerotic plaques. Nat Med 25: 1576-1588.

Indexed at, Google Scholar, Crossref

4. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, et al. (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377: 1119-1131.

Indexed at, Google Scholar, Crossref

5. Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, et al. (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381: 2497-2505.

Indexed at, Google Scholar, Crossref

6. Fiolet AT, Cornel JH, Thompson PL (2020) Colchicine in patients with chronic coronary disease. N Engl J Med 383: 1838-1847.

Indexed at, Google Scholar, Crossref

7. Raj A, Van OA (2008) Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135: 216-226.

Indexed at, Google Scholar, Crossref

8. Perisic L, Aldi S, Sun Y, Folkersen L, Razuvaev A, et al. (2016) Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med 279: 293-308.

Indexed at, Google Scholar, Crossref